West Pharmaceutical Services (WPS) Financial Statements
West Pharmaceutical Services Financial Overview
West Pharmaceutical Services's market cap is currently $25.65B. The company's EPS TTM is $8.97; its P/E ratio is 46.00; and it has a dividend yield of 0.20%. West Pharmaceutical Services is estimated to report earnings on February 18, 2027, and the estimated EPS forecast is $2.04. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 3.07B | $ 2.89B | $ 2.95B | $ 2.89B | $ 2.83B |
| Gross Profit | $ 1.10B | $ 1.00B | $ 1.13B | $ 1.14B | $ 1.17B |
| Operating Income | $ 617.40M | $ 594.60M | $ 710.90M | $ 763.50M | $ 758.70M |
| EBITDA | $ 770.60M | $ 743.80M | $ 844.10M | $ 808.10M | $ 879.70M |
| Net Income | $ 493.70M | $ 492.70M | $ 593.40M | $ 585.90M | $ 661.80M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 791.30M | $ 484.60M | $ 853.90M | $ 894.30M | $ 762.60M |
| Total Assets | $ 4.27B | $ 3.64B | $ 3.83B | $ 3.62B | $ 3.31B |
| Total Debt | $ 416.70M | $ 305.30M | $ 309.00M | $ 317.90M | $ 325.30M |
| Net Debt | $ -374.60M | $ -179.30M | $ -544.90M | $ -576.40M | $ -437.30M |
| Total Liabilities | $ 1.09B | $ 961.10M | $ 948.50M | $ 931.90M | $ 978.40M |
| Stockholders' Equity | $ 3.18B | $ 2.68B | $ 2.88B | $ 2.68B | $ 2.34B |
| Cash Flow | |||||
| Free Cash Flow | $ 468.90M | $ 276.40M | $ 414.50M | $ 439.40M | $ 330.60M |
| Operating Cash Flow | $ 754.80M | $ 653.40M | $ 776.50M | $ 724.00M | $ 584.00M |
| Investing Cash Flow | $ -285.90M | $ -378.70M | $ -368.70M | $ -288.20M | $ -253.10M |
| Financing Cash Flow | $ -185.10M | $ -622.60M | $ -459.60M | $ -293.60M | $ -168.10M |
Currency in USD